Looking for Cheap Income Stocks? Why Pfizer Belongs on Your Shortlist Right Now
Key Points Pfizer is deeply out of favor today, with a historically high dividend yield of 6.9%. The company is…
In-depth analysis on the Fed, earnings, labor, commodities, and the news that moves markets. Filter by topic to find what you’re looking for.
Key Points Pfizer is deeply out of favor today, with a historically high dividend yield of 6.9%. The company is…
Key Points Oracle has a massive $638 billion backlog of contracted revenue and is spending aggressively as a result. There…
Key Points Amazon’s $200 billion in AI spending is supported by strong demand for its Trainium chips and contracted revenue.…
Key Points Ripple created XRP to standardize transactions in its innovative payments network. Ripple just emerged from a legal battle…
Shopping malls aren’t as empty as many Americans think despite the widespread belief that online shopping has kept people at…
Key Points A company’s dividend history is no guarantee of that dividend’s future. That history, however, is still a reasonable…
Key Points The transaction involved the sale of 2,276 shares for approximately ~$181,000 at a weighted-average price of $79.31 per…
Key Points These five industrial companies pair strong balance sheets with powerful AI and electrification growth tailwinds. Low debt and…
Key Points Comparing the iShares U.S. Pharmaceuticals ETF (NYSEMKT:IHE) and the VanEck Biotech ETF (NASDAQ:BBH) reveals two distinct fund profiles.…
Macro shifts, rate moves, and the patterns most investors miss — delivered every week before the market opens.
Trusted by portfolio managers, analysts, and independent investors. No spam. Unsubscribe anytime.
Eagle One Intelligence
Macro shifts, market structure, and the ideas worth tracking — straight to your inbox before the crowd figures it out.